BNR
Burning Rock Biotech Limited (BNR) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
High net debt to EBITDA and negative interest coverage increase refinancing and covenant sensitivity versus peers with cleaner balance sheets, constraining flexibility if operating conditions soften.
A 226-day cash conversion cycle, driven by 126 days of receivables and 151 days of inventory, leaves BNR more working-capital exposed than faster-turn peers.
Long inventory and receivable cycles raise the risk of margin pressure from discounting or write-downs if demand normalizes more slowly than at better-managed peers.
Liquidity ratios are solid, but the gap between current assets and earnings quality means peers with stronger cash generation can absorb volatility more easily.
Opportunities
Strong current and quick ratios provide near-term liquidity headroom versus more levered peers, supporting continuity while the company works through a long cash cycle.
If BNR converts inventory and receivables more efficiently, peers with similar demand exposure but weaker liquidity would face greater strain, improving relative positioning.
The low debt-to-equity ratio versus peers suggests equity capitalization is not the primary constraint, leaving room for operational improvement to translate into better resilience.
Any stabilization in working capital could release cash faster than at peers with structurally tighter liquidity, improving flexibility for growth or balance-sheet repair.
Overall Score
BNR’s strong liquidity is offset by very high leverage on an EBITDA basis and an extended cash conversion cycle, leaving positioning mixed versus peers.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Burning Rock Biotech Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
